Jim Simons acquired 137 Thousand Celldex Therapeutics shares worth $2.67 Million. That's 0.00% of their equity portfolio (1658th largest holding). The first Celldex Therapeutics trade was made in Q1 2019. Since then Jim Simons bought shares nine more times and sold shares on eight occasions. The investor's estimated purchase price is $3.71 Million, resulting in a loss of 28%.